×

Vertex drug faces big test

2:09 PM ET Tue, 12 May 2015

Vertex Pharmaceuticals shares are halted as a panel of advisors to the FDA review the company's experiment treatment for Cystic Fibrosis. CNBC's Meg Tirrell reports.